Skip to main content
Ami B. Patel
( out of 56 reviews )

Ami B. Patel, MD, BS

Languages spoken: English

Clinical Locations

Primary Location

Dr. Ami Patel is an Assistant Professor of Medicine within the Division of Hematology and Hematologic Malignancies at the Huntsman Cancer Institute/University of Utah. She is a hematologist and physician-scientist with an NIH-funded independent translational research program investigating the biology of myeloid malignancies, specifically myeloid leukemogenesis as it relates to the intersection of inflammation, aging and oncogenic kinase signaling. Her clinical practice encompasses the diagnosis and treatment of myelodysplastic/myeloproliferative (MDS/MPN) overlap disorders, myeloproliferative neoplasms (MPNs), and acute myeloid leukemia (AML). Dr. Patel's research focuses on understanding cell signaling in myeloid leukemias and the molecular mechanisms governing drug resistance to targeted agents in these diseases. Her laboratory-based research complements her clinical practice by informing novel treatment strategies for implementation in early-phase clinical trials - with the goal of rapidly translating relevant preclinical findings and improving outcomes for leukemia patients. Dr. Patel's laboratory has specific expertise in studying resistance mechanisms to kinase inhibitors that act upon oncogenic kinases such as MEK1/2, BCR-ABL1, JAK2 and FLT3-ITD. Previously, she found that resistance to the FLT3 inhibitor quizartinib is mediated through soluble factors secreted by bone marrow stromal cells in AML (Patel et al, Leukemia, 2020). Dr. Patel has led the effort to functionally characterize a novel JAK2 insertion-deletion mutant associated with resistance to JAK2 inhibition and clinical features of both polycythemia and hypereosinophilia (Patel et al, Blood, 2019). She is the principal investigator on an investigator-initiated trial (NCT04409639) of the MEK inhibitor cobimetinib in RAS/MAPK-activated chronic myelomonocytic leukemia (CMML) that will help define the efficacy of RAS/MAPK inhibition in this disease and elucidate mechanisms of resistance to oncogenic RAS/MAPK signaling in myeloid leukemias.

To schedule an appointment New Patients: 801-585-4630 Returning patients: 801-585-2626 or schedule through MyChart.

For questions regarding our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist (801) 587-4630.

Board Certification

American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)

Patient Rating

5.0 /5
( out of 56 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


2026-03-20
HUNTSMAN CANCER CENTER

Doctor Patel Is an excellent doctor in every way a doctor should be in meeting the needs of a patient. The Huntsman Hospital is very blessed to have her on their team.

2026-02-12
HUNTSMAN CANCER CENTER

Dr. Ami Patel is so amazing. Her approach in your care gives you complete confidence in your health.

2026-02-03
HUNTSMAN CANCER CENTER

Ami Patel is extremely knowledgeable in her field. I highly recommend her.

2025-11-19
HUNTSMAN CANCER CENTER

Doctor Patel is an excellent doctor.

2025-10-12
HUNTSMAN CANCER CENTER

I feel so fortunate to have Dr. Patel as my physician. She is knowledgeable about my rare condition and always knows the latest research. She explains details about my careplan and my prognosis.

2025-08-22
HUNTSMAN CANCER CENTER

Dr. Patel was so knowledgeable and pleasant to talk to. She was so kind. We will enjoy working with her in the future.

2025-08-03
HUNTSMAN CANCER CENTER

True professional in my opinion.

2025-06-16
HUNTSMAN CANCER CENTER

Both sees the big picture and the pieces which make that picture up = very good assesment.

2025-05-25
HUNTSMAN CANCER CENTER

I accidentally put 'fair' on the last page and didn't mean that at all. Can you change it to the highest rating? Dr. Patel is supernatural in all ways.

2025-01-19
HUNTSMAN CANCER CENTER

Dr Patel really cares about her patients.

2025-01-14
HUNTSMAN CANCER CENTER

A patient oriented physician who showed interest in my needs and concerns.

2025-01-05
HUNTSMAN CANCER CENTER

Outstanding service

2024-12-08
HUNTSMAN CANCER CENTER

Dr. Patel is willing to take all the necessary time to help us understand treatment options, discussing risks and advising, but encouraging us to make the ultimate decision. Her team is equally competent and willing to make adjustments to meet our scheduling needs.

2024-12-08
HUNTSMAN CANCER CENTER

Very knowledgeable and great to talk to.

2024-11-04
HUNTSMAN CANCER CENTER

Dr. Patel was excellent! She took time with us to make sure we understood all the aspected if my diagnosis and treatment and answer the many questions we had. She has a great doctor / patient bedside manner and was very knowledgeable. She explored new research treatment options and shared details and the advantages and disadvantages of each treatment. You can tell she is passionate about her calling in medicine. She was professional and warm. It was a very reassuring experience for me in going forward with my treatment at Huntsman.

2024-10-19
HUNTSMAN CANCER CENTER

Dr. Patel is one of the finest MD's I've every had. She is wonderful!

2024-10-04
HUNTSMAN CANCER CENTER

Very thorough and compassionate

2024-09-26
HUNTSMAN CANCER CENTER

Doctor Patel is an excellent doctor.

2024-09-16
HUNTSMAN CANCER CENTER

Dr Ami B Patel, MD, has been my oncologist for just shy of five years. She is very friendly, kind, caring and gentle. She always greets me with a wonderful smile and makes me feel so comfortable. Dr Patel listens and explains things so I understand. She obviously cares about me and my health journey. I'm so grateful to have Dr Patel as my oncologist.

2024-07-27
HUNTSMAN CANCER CENTER

Very good knowledge on CMML.

2024-07-26
HUNTSMAN CANCER CENTER

Excellent hermatogist would recommend to friends and family very responsive and knowledgeable about CMML

2024-07-03
HUNTSMAN CANCER CENTER

Dr. Patel is a wonderful doctor. She truly cares about her patients as individuals and anticipates their needs. She is amazing at explaining things and taking time to ensure patient understanding. She is truly a gift to her hematology practice. Her staff is equally amazing!

2024-06-14
HUNTSMAN CANCER CENTER

Very thorough and compassion care

2024-06-08
HUNTSMAN CANCER CENTER

I'm a very satisfied and confident in my treatment with Dr Patel. I would recommend her and the whole organization. I have strong confidence in her depth of knowledge and up to date insights for the latest developments for my condition and those of others. I appreciate that she is involved in research also which helps the above I am sure. I hope the entire organization values her greatly and I suspect that it does!

2024-05-12
HUNTSMAN CANCER CENTER

The amazing staff listens to your concerns through to fulfilling your heath care needs. The entire process from checking in to blood draw lab to seeing your doctor is very efficient which eases the stress of patient care. My shinning star is Dr A. Patel who saved me from being overdosed by a previous cancer center. I encourage every person with cancer to see the "A" team of doctors at The University of Health Care.

2024-02-24
HUNTSMAN CANCER CENTER

Dr. Patel could understand the frustration we were feeling when we were not privy to behind the scenes conversations that a team of doctors were having without consulting or informing us. It was a relief to be able to speak with someone with expertise who could answer our questions and take action on our behalf.

2024-02-10
HUNTSMAN CANCER CENTER

Muy atenta y explica todo muy bien!

2024-02-09
HUNTSMAN CANCER CENTER

Excellent care and concetn

2024-02-02
HUNTSMAN CANCER CENTER

Dr Patel combines brilliance with compassion and understanding.

2024-01-28
HUNTSMAN CANCER CENTER

Dr. Patel is always informed and eager to discuss details

2024-01-23
HUNTSMAN CANCER CENTER

Doctor Patel is an excellent doctor.

2024-01-05
HUNTSMAN CANCER CENTER

Concise and caring to with patients

2023-12-23
HUNTSMAN CANCER CENTER

Dr. Patel is extremely competent and listens intently to patient concerns. I have full confidence in her advice.

2023-12-10
HUNTSMAN CANCER CENTER

Dr. Ami Patel is very pleasant, efficient, well prepared, explains very methodically and easily understandable. My consultation with Dr. Ami Patel was an excellent experience.

2023-12-04
HUNTSMAN CANCER CENTER

I feel confident that Dr. Ami Patel is doing her very best to provide an answer and treatment for my condition. She is very knowledgeable. She also treated me with respect and kindness, a valuable attribute in a physician.

2023-11-17
HUNTSMAN CANCER CENTER

Excellent care

2023-10-07
HUNTSMAN CANCER CENTER

She was great in explaining what was happening and how we should proceed and didn't make us feel rushed.

2023-07-25
HUNTSMAN CANCER CENTER

Dr. Patel was familiar with my case and listened to my concerns. She was interested in exploring some other ideas and messaged my with additional information concerning lab results. I found her to be caring, knowledgeable, and concerned about my health. Wonderful provider!

2023-05-31
HUNTSMAN CANCER CENTER

Very detail oriented, caring, friendly and well prepare for every single visit

2023-05-07
HUNTSMAN CANCER CENTER

She was very kind, explained things clearly,

2023-04-09
HUNTSMAN CANCER CENTER

She diligently explained my condition and we made a plan for future events. I love her attitude, she made me feel so comfortable and hopeful.

2023-03-11
HUNTSMAN CANCER CENTER

Excellent doctor. Skilled and knowledgeable

2023-03-05
HUNTSMAN CANCER CENTER

Is is clear that Dr. Patel is extremely knowledgeable. She was very kind, compassionate, and thorough during our appointment. I feel beyond lucky to be under her care.

2023-02-18
HUNTSMAN CANCER CENTER

Doctor Patel is an excellent doctor.

2023-02-09
HUNTSMAN CANCER CENTER

Dr. Patel is a first class physician. She makes me feel like I matter and I have a great deal of confidence in her care.

2023-01-28
HUNTSMAN CANCER CENTER

She listens intently and responds thoughtfully. She always seems upbeat and encouraging.

2023-01-23
HUNTSMAN CANCER CENTER

Dr. Patel is so knowledgeable and really took the time to explain everything about my illness. She made me feel better about my illness and the future.

2023-01-11
HUNTSMAN CANCER CENTER

Dr Ami Patel is the best Dr I have ever had care from!

2022-12-06
HUNTSMAN CANCER CENTER

Dr. Patel and her assistant are very attentive and wonderful to work with and I feel very comfortable in Placing my trust in Their care

2022-12-06
HUNTSMAN CANCER CENTER

Muy agradable

2022-12-05
HUNTSMAN CANCER CENTER

Very very pleased that Dr. Ami Patel Md answered my questions very clearly and I was very satisfied with her explaination.

2022-11-15
Huntsman Cancer Institute

Care provider was great.

2022-10-21
HUNTSMAN CANCER CENTER

Dr. Patel is the best. She has been extremely helpful in dealing with my leukemia. I have a profound regard for Dr. Patel

2022-10-02
HUNTSMAN CANCER CENTER

Dr Ami Patel is very professional with excellent knowledge and has great listening skills!!

2022-09-27
HUNTSMAN CANCER CENTER

Dr. Patel is the best.

2022-08-31
HUNTSMAN CANCER CENTER

Dr Patel takes the time to discuss all aspects of what is going on with my overall health and condition and includes me in all aspects of making decisions and plans going forward.

2022-08-21
HUNTSMAN CANCER CENTER

Dr. Patel helped me a couple of health issues not relayed to my hematology problems. I always feel that she treats me as a whole person not a disease process. I always feel like I get great information. I feel so fortunate that she is my physician.

2022-03-10
HUNTSMAN CANCER CENTER

Dr Patel is an amazing knowledgeable doctor! She takes the time to explain to me in ways I can understand. Then we make my care decisions TOGETHER!

2022-03-06
HUNTSMAN CANCER CENTER

Dr. PATEL IS THE VERY BEST PROVIDER. I FEEL VERY FORTUNATE TO HAVER HER MANAGI G MY HEALTH CARE.

2022-03-05
HUNTSMAN CANCER CENTER

Dr Ami Patel is such a caring MD and has great listening skills and provides world class care!!

2022-02-26
HUNTSMAN CANCER CENTER

I have been dealing with very bad arthritis in my hip and always in extreme pain. Dr Patel showed sincere concern and referred me to an orthopedic surgeon and I received a phone call the very next day for an appointment

2022-02-07
HUNTSMAN CANCER CENTER

Wonderful medical staff

2022-01-13
HUNTSMAN CANCER CENTER

Dr Patel is so knowledgeable! I feel comfortable under her care and confident in her decisions. I appreciate her always taking time to answer all my concerns.

2021-12-11
HUNTSMAN CANCER CENTER

Patel has been VERY GOOD, keeping me informed and concerned for my getting better.

2021-12-03
HUNTSMAN CANCER CENTER

Dr Patel is so knowledgeable, professional and Is so kind and understanding. She Is a world class Dr!!!

2021-11-25
HUNTSMAN CANCER CENTER

Dr Patel was very good at explaining what I can expect to happen next in my care. I feel very safe and confident under her watch.

2021-11-25
HUNTSMAN CANCER CENTER

Good

2021-11-20
HUNTSMAN CANCER CENTER

Very pleased and answered all my questions.

2021-07-31
HUNTSMAN CANCER CENTER

Very informative, listened well, very kind

2021-07-29
HUNTSMAN CANCER CENTER

Dr. Patel is very compassionate, thorough and plain-speaking in her describing my condition and treatment options.

2021-06-17
HUNTSMAN CANCER CENTER

Dr Patel spent considerable time going through all of my test results and making sure I understood each and everyone of them. She also explained what I can look forward to in the future based on each test results. Her care and her concern for my well-being make me feel reassured that I was getting the best care available. She made sure I knew what my options for the future would be, what to worry about and what not to worry about. When One of the tests had not come back yet, she called me at home the next day when it did come back. The results were unexpected so she spent time explaining to me what the results meant. She explained that I would need future testing and said she would arrange for the clinic to call me to set it up. She went above and beyond in her caring and kind attitude and her ability to make sure I understood my medical situation.

2021-06-14
HUNTSMAN CANCER CENTER

I feel so lucky that Dr. Patel is my physician. I know that she up to date on the latest research. She always has a caring attitude.

2021-05-30
HUNTSMAN CANCER CENTER

we talked about some of the symptoms that I have right now in reference to my memory. I was suppose to get a brochure with information but she could not find any information about it. The good thing was that at the meantime a social worker showed up and got information about researching for a new Therapist.

2021-05-27
HUNTSMAN CANCER CENTER

Knowledgeable provider. Explained everything and adds advice.

2021-05-15
HUNTSMAN CANCER CENTER

Asked questions and listened to my answers. Explained the next steps in treatment and what they were for thoroughly. Very kind and made sure I understood.

2021-05-01
HUNTSMAN CANCER CENTER

As a 60 year old with plenty of medical issues I have a small army of doctors, or so it seems at times. I like them all, as I have no problem "firing" doctors I don't trust, but Dr Patel is absolutely the best doctor I have ever interacted with. She is brilliant and personable and I don't want to ever lose her.

2021-03-21
HUNTSMAN CANCER CENTER

Dr Patel is a great listener and communicator. She exhibits care and concern and every appointment and when we communicate. She is clear and I always leave feeling like we have a great game plan.

2021-02-07
HUNTSMAN CANCER CENTER

she changed the doses on the Hydroxyurea to keep my level at my goal.

2021-01-21
HUNTSMAN CANCER CENTER

Dr Patel is the best doctor I've ever had.

2020-10-16
HUNTSMAN CANCER CENTER

Dr. Patel is great. Probably the best MD I have ever seen

2020-09-22
HUNTSMAN CANCER CENTER

Ami Patel is a rock star!!! Her nurses and staff are better than excellent.

2020-09-06
HUNTSMAN CANCER CENTER

Dr. Ami Patel is THE BEST!!!!!

2020-06-28
HUNTSMAN CANCER CENTER

Always forthright about treatment consequences or other options.

2020-06-27
HUNTSMAN CANCER CENTER

what s great and caring staff.

2020-05-17
HUNTSMAN CANCER CENTER

Ami Patel is a rock star!!!!!!!!!!!!!!!!!!!!!!!!

2020-05-09
HUNTSMAN CANCER CENTER

she communicated well

2020-03-07
HUNTSMAN CANCER CENTER

Dr. Patel is amazingly compassionate, professional, charming person. I feel very fortunate to be under her care. Thanks very much, Dr. Patel.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Ami Patel is an Assistant Professor of Medicine within the Division of Hematology and Hematologic Malignancies at the Huntsman Cancer Institute/University of Utah. She is a hematologist and physician-scientist with an NIH-funded independent translational research program investigating the biology of myeloid malignancies, specifically myeloid leukemogenesis as it relates to the intersection of inflammation, aging and oncogenic kinase signaling. Her clinical practice encompasses the diagnosis and treatment of myelodysplastic/myeloproliferative (MDS/MPN) overlap disorders, myeloproliferative neoplasms (MPNs), and acute myeloid leukemia (AML). Dr. Patel's research focuses on understanding cell signaling in myeloid leukemias and the molecular mechanisms governing drug resistance to targeted agents in these diseases. Her laboratory-based research complements her clinical practice by informing novel treatment strategies for implementation in early-phase clinical trials - with the goal of rapidly translating relevant preclinical findings and improving outcomes for leukemia patients. Dr. Patel's laboratory has specific expertise in studying resistance mechanisms to kinase inhibitors that act upon oncogenic kinases such as MEK1/2, BCR-ABL1, JAK2 and FLT3-ITD. Previously, she found that resistance to the FLT3 inhibitor quizartinib is mediated through soluble factors secreted by bone marrow stromal cells in AML (Patel et al, Leukemia, 2020). Dr. Patel has led the effort to functionally characterize a novel JAK2 insertion-deletion mutant associated with resistance to JAK2 inhibition and clinical features of both polycythemia and hypereosinophilia (Patel et al, Blood, 2019). She is the principal investigator on an investigator-initiated trial (NCT04409639) of the MEK inhibitor cobimetinib in RAS/MAPK-activated chronic myelomonocytic leukemia (CMML) that will help define the efficacy of RAS/MAPK inhibition in this disease and elucidate mechanisms of resistance to oncogenic RAS/MAPK signaling in myeloid leukemias.

To schedule an appointment New Patients: 801-585-4630 Returning patients: 801-585-2626 or schedule through MyChart.

For questions regarding our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist (801) 587-4630.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor
Oncological Sciences -Adjunct Assistant Professor
Academic Divisions Hematology & Hematologic Malignancies
Board Certification
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)

Education history

Undergraduate Biology, cum laude - Northwestern University B.S.
Professional Medical Medicine - Northwestern University Feinberg School of Medicine M.D.
Internship Internal Medicine - McGaw Medical Center of Northwestern University Intern
Residency Internal Medicine - McGaw Medical Center of Northwestern University Resident
Fellowship Hematology/Oncology - University of Utah School of Medicine Fellow
Fellowship Hematology/Oncology Fellowship Program - University of Utah School of Medicine Chief Fellow
Fellowship Hematology/Oncology Research - University of Utah Advanced Fellow

Selected Publications

Journal Article

  1. Patel AB, Franzini A, Leroy E, Kim SJ, Pomicter AD, Genet L, Xiao M, Yan D, Ahmann JM, Agarwal AM, Clair P, Addada J, Lambert J, Salmon M, Gleich GJ, Cross NCP, Constantinescu SN, O'Hare T, Prchal JT, Deininger M (2019). JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera. Blood, 134(26), 2388-2398.
  2. Antelope O, Vellore NA, Pomicter AD, Patel AB, Van Scoyk A, Clair PM, Deininger MW, O'Hare (2019). BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits preclinical activity in Philadelphia chromosome-positive leukemia. Experimental hematology, 77, 36-40.e2.
  3. Patel AB, Pomicter AD, Yan D, Eiring AM, Antelope O, Schumacher JA, Kelley TW, Tantravahi SK, Kovacsovics TJ, Shami PJ, O'Hare T, Deininger M (2020). Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms. Leukemia, 34(11), 2981-2991.
  4. Patel AB, Miles RR, Deininger M (2019). Lysozyme nephropathy in chronic myelomonocytic leukemia. Clinical case reports, 7(6), 1263-1264.
  5. Patel AB, Pettijohn EM, Abedin SM, Raps E, Deininger M (2019). Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations. Blood advances, 3(7), 952-955.
  6. Yan D, Franzini A, Pomicter AD, Halverson BJ, Antelope O, Mason CC, Ahmann JM, Senina AV, Vellore NA, Jones CL, Zabriskie MS, Than H, Xiao MJ, van Scoyk A, Patel AB, Clair PM, Heaton WL, Owen SC, Andersen JL, Egbert CM, Reisz JA, D'Alessandro A, Cox JE, Gantz KC, Redwine HM, Iyer SM, Khorashad JS, Rajabi N, Olsen CA, O'Hare T, Deininger M (2021). SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA. Blood cancer discovery, 2(3), 266-287.
  7. Patel AB, Chen YH, Zhang Y, Frankfurt O, Winter J (2015). Achievement of morphologic and cytogenetic remission with single-agent hydroxyurea in a patient with acute myeloid leukemia with inv(16). Leukemia & lymphoma, 56(3), 817-9.
  8. Li P, Alnoor FNU, Xie W, Williams M, Feusier J, Ding Y, Zhao X, Zheng G, Zhao C, Zieske AW, Zu Y, Raess PW, Tantravahi S, Osman A, Patel AB, Tashi T, Patel JL, Matynia AP, Menon MP, Miles RR, Jacobsen JR, George TI, Sborov DW, Szankasi P, Rindler P, Close D, Ohgami R (2025). Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS. Leukemia, 39(1), 248-256.
  9. Vardell VA, Ose J, Rets AV, Tantravahi SK, Patel A (2024). Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis. Clinical lymphoma, myeloma & leukemia, 24(12), 843-851.
  10. Zhukovsky S, Rets A, Braaten T, Patel A (2024). VEXAS without vacuoles: Linking genotype to phenotype. EJHaem, 5(5), 981-986.
  11. Gillis N, Dickey BL, Colin-Leitzinger C, Tang YH, Putney RM, Mesa TE, Yoder SJ, Suneja G, Spivak AM, Patel AB, Extermann M, Giuliano AR, Teng M, Kresovich J, Berglund A, Coghill A (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of infectious diseases, 230(3), 680-688.
  12. Kaur A, Rojek AE, Symes E, Nawas MT, Patel AA, Patel JL, Sojitra P, Aqil B, Sukhanova M, McNerney ME, Wu LP, Akmatbekov A, Segal J, Tjota MY, Gurbuxani S, Cheng JX, Yeon SY, Ravisankar HV, Fitzpatrick C, Lager A, Drazer MW, Saygin C, Wanjari P, Katsonis P, Lichtarge O, Churpek JE, Ghosh SB, Patel AB, Menon MP, Arber DA, Wang P, Venkataraman (2024). Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood cancer journal, 14(1), 99.
  13. Osman AEG, Rets A, Patel A (2024). KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia. Leukemia research, 138, 107466.
  14. Krah NM, Miotke L, Li P, Patel JL, Bowen AR, Pomicter AD, Patel A (2023). JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome. Journal of the National Comprehensive Cancer Network, 21(12), 1218-1223.
  15. Dickey BL, Putney RM, Suneja G, Kresovich JK, Spivak AM, Patel AB, Teng M, Extermann M, Giuliano AR, Gillis N, Berglund A, Coghill A (2023). Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer. AIDS (London, England), 37(13), 2049-2057.
  16. Krah NM, Hoeg R, Shami PJ, Elf SE, Lee LE, Pemmaraju N, Patel A (2025). Real-world management of blastic plasmacytoid dendritic cell neoplasm at an academic center with a broad regional referral base. Leukemia research reports, 24, 100541.
  17. Arellano NS, Heaton WL, Nauman MC, Runnels AE, Gomez-Villa J, Vanni D, Gaviria M, Fujita M, Krah NM, Ciboddo M, Yadav S, Brown CT, Bowden PD, Chen AK, Henning C, Catricalà S, Casetti IC, Borsani O, Rumi E, Pietra D, Plo I, Marty C, Marchetti M, Patel AB, Saygin C, Elf S (2025). Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms. Blood, 146(8), 971-983.
  18. Pandiri M, Stengel A, Zhang J, Wang P, Shao H, Velmurugan S, Jacob A, Symes E, Kaur A, Rojek A, Sojitra P, Wiredja D, Zhou Q, Chang H, Patil E, Patel JL, Patel AB, Menon M, Ghosh S, Wool GD, Arber DA, Pan Z, Findley A, Badar T, Tariq H, Sallman D, Bell RC, Perry A, Haferlach C, Fitzpatrick C, Venkataraman (2025). Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. Journal of clinical pathology, 78(9), 629-635.
  19. Gotlib J, Gerds AT, Abdelmessieh P, Ali H, Castells M, Dunbar A, Fein Revell R, George TI, Green S, Gundabolu K, Hexner E, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, Manchanda N, Masarova L, May J, McMahon B, Mohan SR, Nadiminti KV, Oh S, Palmer J, Patel A, Patel AA, Podoltsev N, Rein L, Salit R, Talpaz M, Wadleigh M, Wall S, Bergman MA, Hochstetler (2024). NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024. Journal of the National Comprehensive Cancer Network, 22(2 D),

Review

  1. Patel AB, Deininger M (2021). Genetic complexity of chronic myelomonocytic leukemia. Leukemia & lymphoma, 62(5), 1031-1045.
  2. Patel AB, Masarova L, Mesa RA, Hobbs G, Pemmaraju (2024). Polycythemia vera: past, present and future. Leukemia & lymphoma, 65(11), 1552-1564.